Life Sciences Voice Top Five Newsletter

February 19, 2025

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

July 20, 2026

Following FDA rejection, AstraZeneca finally gives up US rights to roxadustat

February 29, 2024

Must Read

FDA Approves Eli Lilly’s Mounjaro to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

September 3, 2026

Roche’s Genentech Partners With DualityBio on ADCs Designed to Address Cancer Drug Resistance

September 3, 2026

Top 10 Technologies Improving Market Access in Pharma

September 3, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

Ambros and Werewolf Merge as Neridronate Advances in Phase 3 Trial for CRPS-1

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Roche’s Genentech Partners With DualityBio on ADCs Designed to Address Cancer Drug Resistance

Cureety Buys Out AI-Focused Oncology Firm Reimagine Care

Novartis and Alteogen sign a $3.2 billion subcutaneous medication delivery agreement

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Top 10 Technologies Improving Market Access in Pharma

Top 10 Innovations in Target Identification in Drug Development

Top 10 Data Governance Priorities for Life Sciences Leaders

Agentic AI in Life Sciences

Tag: Cureety Acquisition

Cureety Buys Out AI-Focused Oncology Firm Reimagine Care

Editor Picks

Life Sciences Voice Top Five Newsletter

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

Following FDA rejection, AstraZeneca finally gives up US rights to roxadustat

Must Read

FDA Approves Eli Lilly’s Mounjaro to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

Roche’s Genentech Partners With DualityBio on ADCs Designed to Address Cancer Drug Resistance

Top 10 Technologies Improving Market Access in Pharma

Hot Topics

About Us

Follow Us